お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は化学療法に伴う悪心・嘔吐（CINV）市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは化学療法に伴う悪心・嘔吐（CINV）の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の化学療法に伴う悪心・嘔吐（CINV）市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは化学療法に伴う悪心・嘔吐（CINV）のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に化学療法に伴う悪心・嘔吐（CINV）市場を分類しています。本研究に含まれる主な企業は：Merck、Eisai、ProStrakan、Helsinn Holding、Mundipharma、Qilu Pharma、Teva、Novartis、Heron Therapeutics、Roche、Mylan、Tesaro

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    CINV
    PONV

用途別の市場セグメント：
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers

本レポートの詳細内容
世界の化学療法に伴う悪心・嘔吐（CINV）市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、化学療法に伴う悪心・嘔吐（CINV）タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の化学療法に伴う悪心・嘔吐（CINV）収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の化学療法に伴う悪心・嘔吐（CINV）市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、化学療法に伴う悪心・嘔吐（CINV）市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

化学療法に伴う悪心・嘔吐（CINV）のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：化学療法に伴う悪心・嘔吐（CINV）のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：化学療法に伴う悪心・嘔吐（CINV）の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章化学療法に伴う悪心・嘔吐（CINV）企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：化学療法に伴う悪心・嘔吐（CINV）の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：化学療法に伴う悪心・嘔吐（CINV）の主要企業の概要を提供し、製品の説明と仕様、化学療法に伴う悪心・嘔吐（CINV）の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
Market Analysis and Insights: Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market is projected to grow from US$ 2625.4 million in 2024 to US$ 3044.6 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
Report Covers:
This report presents an overview of global market for Chemotherapy-Induced Nausea and Vomiting (CINV) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Chemotherapy-Induced Nausea and Vomiting (CINV), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Chemotherapy-Induced Nausea and Vomiting (CINV), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Chemotherapy-Induced Nausea and Vomiting (CINV) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Chemotherapy-Induced Nausea and Vomiting (CINV) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Chemotherapy-Induced Nausea and Vomiting (CINV) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Eisai, ProStrakan, Helsinn Holding, Mundipharma, Qilu Pharma, Teva, Novartis and Heron Therapeutics, etc.

Market Segmentation
By Company
    Merck
    Eisai
    ProStrakan
    Helsinn Holding
    Mundipharma
    Qilu Pharma
    Teva
    Novartis
    Heron Therapeutics
    Roche
    Mylan
    Tesaro

Segment by Type
    CINV
    PONV

Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Diagnostic Centers

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chemotherapy-Induced Nausea and Vomiting (CINV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemotherapy-Induced Nausea and Vomiting (CINV) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemotherapy-Induced Nausea and Vomiting (CINV) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of CINV
    Table 3. Key Players of PONV
    Table 4. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2019-2024)
    Table 8. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2025-2030)
    Table 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Trends
    Table 11. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Drivers
    Table 12. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Challenges
    Table 13. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Restraints
    Table 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players (2019-2024)
    Table 16. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2023)
    Table 17. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Headquarters and Area Served
    Table 20. Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Product and Application
    Table 21. Global Key Players of Chemotherapy-Induced Nausea and Vomiting (CINV), Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2019-2024)
    Table 25. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Type (2025-2030)
    Table 27. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2019-2024)
    Table 29. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2025-2030)
    Table 31. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Merck Company Details
    Table 64. Merck Business Overview
    Table 65. Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 66. Merck Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 67. Merck Recent Developments
    Table 68. Eisai Company Details
    Table 69. Eisai Business Overview
    Table 70. Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 71. Eisai Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 72. Eisai Recent Developments
    Table 73. ProStrakan Company Details
    Table 74. ProStrakan Business Overview
    Table 75. ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 76. ProStrakan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 77. ProStrakan Recent Developments
    Table 78. Helsinn Holding Company Details
    Table 79. Helsinn Holding Business Overview
    Table 80. Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 81. Helsinn Holding Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 82. Helsinn Holding Recent Developments
    Table 83. Mundipharma Company Details
    Table 84. Mundipharma Business Overview
    Table 85. Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 86. Mundipharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 87. Mundipharma Recent Developments
    Table 88. Qilu Pharma Company Details
    Table 89. Qilu Pharma Business Overview
    Table 90. Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 91. Qilu Pharma Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 92. Qilu Pharma Recent Developments
    Table 93. Teva Company Details
    Table 94. Teva Business Overview
    Table 95. Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 96. Teva Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 97. Teva Recent Developments
    Table 98. Novartis Company Details
    Table 99. Novartis Business Overview
    Table 100. Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 101. Novartis Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 102. Novartis Recent Developments
    Table 103. Heron Therapeutics Company Details
    Table 104. Heron Therapeutics Business Overview
    Table 105. Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 106. Heron Therapeutics Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 107. Heron Therapeutics Recent Developments
    Table 108. Roche Company Details
    Table 109. Roche Business Overview
    Table 110. Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 111. Roche Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 112. Roche Recent Developments
    Table 113. Mylan Company Details
    Table 114. Mylan Business Overview
    Table 115. Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 116. Mylan Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 117. Mylan Recent Developments
    Table 118. Tesaro Company Details
    Table 119. Tesaro Business Overview
    Table 120. Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Product
    Table 121. Tesaro Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024) & (US$ Million)
    Table 122. Tesaro Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type: 2023 VS 2030
    Figure 3. CINV Features
    Figure 4. PONV Features
    Figure 5. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application: 2023 VS 2030
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Diagnostic Centers Case Studies
    Figure 10. Chemotherapy-Induced Nausea and Vomiting (CINV) Report Years Considered
    Figure 11. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region: 2023 VS 2030
    Figure 14. Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Players in 2023
    Figure 15. Global Top Chemotherapy-Induced Nausea and Vomiting (CINV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy-Induced Nausea and Vomiting (CINV) as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue in 2023
    Figure 17. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2019-2030)
    Figure 19. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2019-2030)
    Figure 20. North America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2019-2030)
    Figure 21. United States Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2019-2030)
    Figure 25. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2019-2030)
    Figure 26. Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2019-2030)
    Figure 27. Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2019-2030)
    Figure 35. China Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2019-2030)
    Figure 36. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2019-2030)
    Figure 38. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2019-2030)
    Figure 39. Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Region (2019-2030)
    Figure 40. Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share by Country (2019-2030)
    Figure 50. Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Merck Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 57. Eisai Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 58. ProStrakan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 59. Helsinn Holding Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 60. Mundipharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 61. Qilu Pharma Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 62. Teva Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 63. Novartis Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 64. Heron Therapeutics Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 65. Roche Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 66. Mylan Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 67. Tesaro Revenue Growth Rate in Chemotherapy-Induced Nausea and Vomiting (CINV) Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed